Animalcare Group plc (AIM:ANCR)

London flag London · Delayed Price · Currency is GBP · Price in GBX
333.00
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2026
Market Cap229.92M +55.7%
Revenue (ttm)81.07M +11.9%
Net Income2.98M -83.8%
EPS0.05 -85.1%
Shares Out 69.05M
PE Ratio73.78
Forward PE22.38
Dividend0.05 (1.56%)
Ex-Dividend Daten/a
Volume2,115,670
Open332.50
Previous Close333.00
Day's Range325.00 - 335.00
52-Week Range216.00 - 340.00
Beta0.49
Analystsn/a
Price Targetn/a
Earnings DateMar 27, 2026

About Animalcare Group

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Asia, the Middle East, Africa, European Union, and internationally. Animalcare Group plc is based in York, ... [Read more]

Sector Healthcare
CEO Jennifer Ann Winter
Employees 201
Stock Exchange London Stock Exchange AIM
Ticker Symbol ANCR
Full Company Profile

Financial Performance

In 2024, Animalcare Group's revenue was 74.23 million, an increase of 4.94% compared to the previous year's 70.73 million. Earnings were 18.49 million, an increase of 1442.45%.

Financial Statements

News

Animalcare Group Annual report: H2 2025

Animalcare Group has published its H2 2025 annual report on May 6, 2026.

4 weeks ago - Filings

Animalcare Group Annual report: H2 2025

Animalcare Group has published its H2 2025 annual report on May 6, 2026.

4 weeks ago - Filings

AIM Market Roundup: Animalcare, Mothercare, Strip Tinning

Animalcare, Mothercare, Strip Tinning are today's top risers, while Quantum Blockchain, Wellnex Life take the biggest fall on London's AIM

6 weeks ago - The Armchair Trader

Animalcare Group Transcript: CMD 2026

Ambitious plans target GBP 150 million revenue by 2030, driven by organic growth, innovation, and M&A, with a focus on commercial excellence, manufacturing consolidation, and a robust R&D pipeline. Equine and dental franchises, along with global expansion and disciplined capital allocation, underpin the strategy.

3 months ago - Transcripts

Animalcare Group Slides: FY 2026

Animalcare Group has posted slides in relation to its FY 2026 quarterly earnings report, which was published on March 4, 2026.

3 months ago - Filings

Animalcare Group Earnings release: Trading update

Animalcare Group released its earnings on January 22, 2026, summarizing the period's financial results.

4 months ago - Filings

Half Year 2025 Animalcare Group plc Investor Presentation Transcript

Half Year 2025 Animalcare Group plc Investor Presentation Transcript

7 months ago - GuruFocus

Animalcare Group Earnings Call Transcript: H1 2025

Revenue grew 18.3% year-over-year, driven by Randlab's strong integration and organic performance. Margins and cash flow improved, with robust investment in R&D and a healthy M&A pipeline. Regulatory and FX headwinds were managed, and the outlook remains positive.

8 months ago - Transcripts

Animalcare Group Quarterly report: H1 2025

Animalcare Group has published its H1 2025 quarterly earnings report on October 6, 2025.

8 months ago - Filings

Animalcare Group Slides: H1 2025

Animalcare Group has posted slides in relation to its H1 2025 quarterly earnings report, which was published on October 6, 2025.

8 months ago - Filings

Animalcare sees revenue growth and improved cash position

Animalcare has a transformational year as disposal of Identicare and STEM sees cash position swell to GBP32.9m

1 year ago - The Armchair Trader